Association between risk of type 2 diabetes mellitus and angiotensin-converting enzyme insertion/deletion gene polymorphisms in a Saudi Arabian population

Al-Saikhan,Fahad I.; Abd-Elaziz,Mohamed A.; Ashour,Rehab H.

doi:10.3892/br.2017.920

Association between risk of type 2 diabetes mellitus and angiotensin-converting enzyme insertion/deletion gene polymorphisms in a Saudi Arabian population

Authors:
- Fahad I. Al-Saikhan
- Mohamed A. Abd-Elaziz
- Rehab H. Ashour
View Affiliations

Affiliations: Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia, Department of Clinical Pharmacology, Mansoura Faculty of Medicine, Mansoura University, Mansoura, Al-Dakahlia 35516, Egypt
Published online on: June 1, 2017 https://doi.org/10.3892/br.2017.920
Pages: 56-60

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The link between the angiotensin‑converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism and the prevalence of type 2 diabetes mellitus (T2DM) developing in the Saudi Arabian population remains controversial. The aim of the present study was to evaluate the association between the ACE I/D gene polymorphism and the risk of developing T2DM and hypertension (HTN) in Saudi Arabian individuals. A total of 220 individuals consisting of 48 control subjects, 70 T2DM, 48 HTN, and 54 T2DM with HTN patients were recruited. Genotyping was performed by polymerase chain reaction initially and mistyping of the DD genotypes was conducted with an insertion‑specific primer. The genotyping frequency for the II, ID and DD polymorphism of the ACE gene was 6.8, 42.6 and 48.6% in T2DM patients, 4.2, 50 and 45.8% in HTN patients, 5.6, 55.5 and 38.9% in T2DM patients with HTN and 58.3, 37.5 and 4.2% in control subjects, respectively. The frequency for the D allele was 70% in T2DM patients, 70.8% in HTN patients and 66.7% in T2DM patients with HTN as compared with 22.9% in the control subjects. The genotype and allele frequency of the ACE gene polymorphism varied significantly (P<0.05) in the patients when compared with the control subjects. The current study demonstrated that the ID/DD genotype and the D allele of the ACE gene I/D polymorphism were strongly associated with the risk of T2DM and HTN developing in a Saudi Arabian population.

View Figures

View References

1	Robert AA, Al Dawish MA, Braham R, Musallam MA, Al Hayek AA and Al Kahtany NH: Type 2 Diabetes Mellitus in Saudi Arabia: Major Challenges and Possible Solutions. Curr Diabetes Rev. 13:59–64. 2017. View Article : Google Scholar : PubMed/NCBI
2	Al Dawish MA, Robert AA, Braham R, Al Hayek AA, Al Saeed A, Ahmed RA and Al Sabaan FS: Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature. Curr Diabetes Rev. 12:359–368. 2016. View Article : Google Scholar : PubMed/NCBI
3	Ramachandran V, Ismail P, Stanslas J, Shamsudin N, Moin S and Jas R Mohd: Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in Malaysian subjects. J Renin Angiotensin Aldosterone Syst. 9:208–214. 2008. View Article : Google Scholar : PubMed/NCBI
4	Zhu X, Cshang YP, Yan D, Weder A, Cooper R, Luke A, Kan D and Chakravarti A: Associations between hypertension and genes in the renin angiotensin system. Hypertension. 41:1027–1034. 2003. View Article : Google Scholar : PubMed/NCBI
5	Dahm KA Jandeleit, Tikellis C, Reid CM, Johnston CI and Cooper ME: Why blockade of the renin angiotensin system reduces the incidence of new onset diabetes. J Hypertens. 23:463–473. 2005. View Article : Google Scholar : PubMed/NCBI
6	Qu H, Lu Y and Lin S: Meta analysis on the association of ACE/ID polymorphism and essential hypertension in Chinese population. Zhonghua Yu Fang Yi Xue Za Zhi. 35:408–411. 2001.(In Chinese). PubMed/NCBI
7	Jeng JR, Harn HJ, Jeng CY, Yueh KC and Shieh SM: Angiotensin I converting enzyme gene polymorphism in Chinese patients with hypertension. Am J Hypertens. 10:558–561. 1997. View Article : Google Scholar : PubMed/NCBI
8	Kennon B, Petrie JR, Small M and Connell JM: Angiotensin converting enzyme gene and diabetes mellitus. Diabet Med. 16:448–558. 1999. View Article : Google Scholar : PubMed/NCBI
9	Chiang FT, Lai ZP, Chern TH, Tseng CD, Hsu KL, Lo HM and Tseng YZ: Lack of association of the angiotensin converting enzyme polymorphism with essential hypertension in a Chinese population. Am J Hypertens. 10:197–201. 1997. View Article : Google Scholar : PubMed/NCBI
10	Barley J, Blackwood A, Cartere ND, Crews DE, Cruickshank JK, Jeffery S, Ogunlesi AO and Sagnella GA: Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens. 12:955–957. 1994. View Article : Google Scholar : PubMed/NCBI
11	O'Donell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH and Levy D: Evidence for association and genetic linkage of the angiotensin converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation. 97:1766–1772. 1998. View Article : Google Scholar : PubMed/NCBI
12	American Diabetes Association, . Standards of Medical Care in Diabetes-2016 Abridged for Primary Care Providers. Clinical Diabetes: A Publication of the American Diabetes Association. 34:3–21. 2016. View Article : Google Scholar : PubMed/NCBI
13	WHO expert consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 157:1632004.
14	Tremblay AJ, Morrissette H, Gagné JM, Bergeron J, Gagné C and Couture P: Validation of the Friedewald formula for the determination of low density lipoprotein cholesterol compared with β quantification in a large population. Clin Biochem. 37:785–790. 2004. View Article : Google Scholar : PubMed/NCBI
15	Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285:2486–2497. 2001. View Article : Google Scholar : PubMed/NCBI
16	Knoell DL, Johnston JS, Bao S and Kelley KA: A genotyping exercise for pharmacogenetics in pharmacy practice. Am J Pharm Educ. 73:432009. View Article : Google Scholar : PubMed/NCBI
17	Rigat B, Hubert C, Gelas F Alhenc, Cambien F, Corvol P and Soubrier F: An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86:1343–1346. 1990. View Article : Google Scholar : PubMed/NCBI
18	Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, Passa P and Gelas F Alhenc: Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complication. Diabetes. 43:384–388. 1994. View Article : Google Scholar : PubMed/NCBI
19	Samani N, Thompson JR, O'Toole L, Channer K and Woods KL: A meta analysis of the association of the deletion allele of the angiotensin converting enzyme gene with myocardial infarction. Circulation. 94:708–712. 1996. View Article : Google Scholar : PubMed/NCBI
20	Zee RY, Lou YK, Griffiths LR and Morris BJ: Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun. 184:9–15. 1992. View Article : Google Scholar : PubMed/NCBI
21	Daimon M, Oizumi T, Saitoh T, kameda W, hirata A, Yamaguchi H, Ohnuma H, igarashi M, Tominaga M and Takeo KA: The D allele of the angiotensin converting enzyme insertion/deletion (I/D) polymorphism is a risk factor for type 2 diabetes in a population based Japanese sample. Endocr J. 50:393–398. 2003. View Article : Google Scholar : PubMed/NCBI
22	Hsieh MC, Lin SR, Hsieh TJ, Hsu CH, Chen HC, Shin SJ and Tsai JH: Increased frequency of angiotensin converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant. 15:1008–1013. 2000. View Article : Google Scholar : PubMed/NCBI
23	Say YH, Ling KH, Duraisamy G, Isaac S and Rosli R: Angiotensinogen M235T gene variants and its association with essential hypertension and plasma renin activity in Malaysian subjects: A case control study. BMC Cardiovasc Disord. 5:72005. View Article : Google Scholar : PubMed/NCBI
24	Vasudevan R, Patimah I, Johnson S and Norashikin S: No association of BglI dimorphism of human renin gene in hypertensive subjects in Malaysia. Res J Biol Sci. 3:1218–1822. 2008.
25	Ghazali DM, Rehman A and Rahman AR: Candidate gene polymorphisms and their association with hypertension in Malays. Clin Chim Acta. 388:46–50. 2008. View Article : Google Scholar : PubMed/NCBI
26	Tseng CH, Tseng CP, Chong CK, Sheu JJ and Cheng JC: Angiotensin converting enzyme gene polymorphism and stroke in type 2 diabetic patients in Taiwan. Eur J Clin Invest. 37:483–491. 2007. View Article : Google Scholar : PubMed/NCBI
27	Nikzamir A, Nakhjavani M, Golmohamadi T and Dibai L: Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes mellitus. Arch Iran Med. 11:3–9. 2008.PubMed/NCBI